propiverine
Small moleculeexperimental
Clinical trial activity
12 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
6
Phase 3
5
Phase 4
2
Earliest trial started Mar 1, 2003 (NCT00646880)
Timeline
Indications
Approved for
Mechanism of action
- L-type calcium channelINHIBITOR
L-type calcium channel inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1- Mol. weight
- 367.49 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1078261 ↗
Also known as
- alpha-diphenyl alpha-n-propoxyacetic acid-4(1-methylpiperidyl)ester
- detrunorm
- detrunorm
- detrunorm
- detrunorm xl
- mictonetten
- mictonorm
- mictonorm
- mictonorm
- propiverin
- propiverin
- propiverin
- propiverine
- propiverine
- propiverine
- propiverine
- propiverine
- propiverine
- propiverine
- propiverine hcl
- propiverine hcl
- propiverine hcl
- propiverine hydrochloride
- propiverine hydrochloride
- propiverine hydrochloride
- propiverine hydrochloride
- propiverine hydrochloride
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05490082 | Phase 3 | Mar 1, 2022 | Mansoura University |
| NCT03844581 | N/A | Jan 1, 2019 | Cairo University |
| NCT03662893 | N/A | Jan 1, 2015 | Government of Turkey, University of Ankara |
| NCT02294396 | Phase 4 | Oct 1, 2014 | Astellas |
| NCT01942681 | N/A | Sep 1, 2013 | Shinshu University, Translational Research Informatics Center, Kobe, Hyogo, Japan |
| NCT01499069 | N/A | Feb 1, 2010 | Sungkyunkwan University |
| NCT01512004 | Phase 3 | Jan 1, 2010 | APOGEPHA Arzneimittel GmbH, Lee's Pharmaceutical |
| NCT00903045 | Phase 4 | Jan 1, 2005 | Sungkyunkwan University |
| NCT01530620 | Phase 3 | Dec 1, 2004 | APOGEPHA Arzneimittel GmbH |
| NCT00795925 | Phase 2 | Oct 1, 2004 | APOGEPHA Arzneimittel GmbH |
| NCT00603343 | Phase 3 | Jun 1, 2004 | APOGEPHA Arzneimittel GmbH |
| NCT00646880 | Phase 3 | Mar 1, 2003 | Pfizer |
Showing 12 of 12 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| APOGEPHA Arzneimittel GmbH | For profit | 4 | 3 | 2 | 2004 |
| Sungkyunkwan University | Academic/Hospital | 2 | 2 | 2 | 2005 |
| Astellas | For profit | 1 | 1 | 1 | 2014 |
| Cairo University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Government of Turkey | Government | 1 | 0 | 1 | 2015 |
| Lee's Pharmaceutical | For profit | 1 | 1 | 1 | 2010 |
| Mansoura University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Pfizer | For profit | 1 | 1 | 1 | 2003 |
| Shinshu University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Translational Research Informatics Center, Kobe, Hyogo, Japan | Academic/Hospital | 1 | 1 | 1 | 2013 |
| University of Ankara | Academic/Hospital | 1 | 1 | 1 | 2015 |
11 organizations
Page 1 / 1